NDC 50090-0139-01 - Hydralazine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0139
- Requested NDC
- 50090-0139-01
- Package NDCs from labels
- 50090-0139-4, 50090-0139-1, 50090-0139-3, 50090-0139-0, 50090-0139-2, 50090-0139-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydralazine Hydrochloride - A-S Medication Solutions | A-S Medication Solutions | 2025-12-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0139-0 | Hydralazine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0139-1 | Hydralazine Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0139-2 | Hydralazine Hydrochloride | 180 in 1 BOTTLE | TABLET | 180 | 31 | |
| 50090-0139-3 | Hydralazine Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 31 | |
| 50090-0139-4 | Hydralazine Hydrochloride | 270 in 1 BOTTLE | TABLET | 270 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0139 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 27 | Current NDC, Legacy NDC, 5 package rows | 20230623_f16f1d87-f9e6-4555-9baf-26ff17cb1d28.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0139-1 | EA - Each | 50090-0139 | 909665fd-356e-4420-8e10-37dd14f0f8e2 | 1 | 2021-05-05 |
| 50090-0139-2 | EA - Each | 50090-0139 | 504f769f-0c65-482e-baf1-0ffe9f65ff64 | 1 | 2021-05-05 |
| 50090-0139-3 | EA - Each | 50090-0139 | 60697e64-520d-4838-9848-a18d3df45535 | 1 | 2021-05-05 |
| 50090-0139-4 | EA - Each | 50090-0139 | 8460a52a-9377-4614-aab4-ed33eb38415c | 1 | 2021-05-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE | ACTIVE INGREDIENT | FD171B778Y | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| HYDRALAZINE | ACTIVE MOIETY | 26NAK24LS8 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | HYDRALAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | d4509f69-e60e-4440-957b-5c2714480335 | 2023-11-27 | Warnings, Adverse reactions | 905222 FD171B778Y |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 4ELV7Z65AP |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | e617023e-b060-4db9-a97e-e2b11a37901e | 2023-08-28 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Bryant Ranch Prepack | 62475f78-5410-43c2-a11d-54a8363c3ae1 | 2023-07-25 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 7979c865-737d-d999-e053-2a91aa0abc5e | 2023-05-16 | Warnings, Adverse reactions | FD171B778Y |
| HydrALAZINE hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | d89d981d-64cf-7321-e053-2995a90aab4a | 2023-05-03 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | dd2cd8a1-7bdd-05e4-e053-2995a90ad366 | 2023-05-02 | Warnings, Adverse reactions | FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Cadila Pharmaceuticals Limited | 3a7562a8-2f67-4411-ac4a-ab7924193e82 | 2022-12-29 | Warnings, Adverse reactions | 905225 905395 905222 FD171B778Y |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c3797028-c625-4f70-ae69-8a5f6f23f1b8 | 2022-08-09 | Warnings, Adverse reactions | FD171B778Y |
| isosorbide dinitrate and hydralazine hydrochloride | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | Wilshire Pharmaceuticals | 620a0680-aad0-4923-84be-7393c0cbdcbd | 2022-04-14 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Radha Pharmaceuticals, Inc. | 149fa857-30ad-451d-b6e2-0000483ccc97 | 2021-03-12 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ScieGen Pharmaceuticals, Inc. | 500b7f76-5f4e-4e7d-85c3-18b9f66d7504 | 2021-03-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Exelan Pharmaceuticals Inc. | 811831f9-a844-463a-874d-fb8407659f0b | 2020-09-04 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 63f388e0-9f3d-4902-990c-9a105aa098ad | 2020-09-01 | Warnings, Adverse reactions | 905225 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | dfd60a79-2a30-41e6-b000-a144730099a8 | 2019-10-01 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 48cf71dd-19dc-4239-9117-ebcf9731a45d | 2019-10-01 | Warnings, Adverse reactions | ANDA040901 905199 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | American Regent, Inc. | 17210abc-58f6-442e-8ff2-7971333c82f6 | 2019-05-06 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Ascend Laboratories, LLC | e7bfec3d-5222-4a26-8f99-6c2a28e14aa6 | 2017-12-28 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | bfbd5960-ae6b-46f5-adfa-e330d7a21dfa | 2017-12-21 | Warnings, Adverse reactions | 905225 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 921c8693-84c2-4313-a2a6-ab3be637d554 | 2016-07-14 | Warnings, Adverse reactions | 905222 FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.